Barbeau A, Bertrand M, Bouchard R, Gauthier G L, Bouchard J P
Can J Neurol Sci. 1982 May;9(2):239-42. doi: 10.1017/s0317167100044036.
To test the physiological significance in vivo of our previous in vitro finding of reduced valine dehydrogenase (VDH) activity in patients with Friedreich's Ataxia, we subjected ataxic patients and controls to an oral valine load test (1.0g) and measured the levels of branched chain alpha-keto acids in the plasma for 24 hours. We demonstrated a significantly higher peak for a alpha-keto isovaleric acid in Friedreich's Ataxia and a general trend towards higher than control values in all other alpha-keto acids measured, and at all times in the experiment. These changes are compatible with the postulated defect in regulation of the activity of VDH in this illness, but because of their small amplitude, they also indicate that a VDH deficiency is not the genetic defect in Friedreich's Ataxia.
为了测试我们之前体外研究发现的弗里德赖希共济失调患者体内缬氨酸脱氢酶(VDH)活性降低的生理意义,我们让共济失调患者和对照组接受口服缬氨酸负荷试验(1.0克),并在24小时内测量血浆中支链α-酮酸的水平。我们发现,弗里德赖希共济失调患者的α-酮异戊酸峰值显著更高,并且在实验的所有时间点,所有其他测量的α-酮酸都呈现出高于对照组值的总体趋势。这些变化与该疾病中VDH活性调节的假定缺陷相符,但由于其幅度较小,也表明VDH缺乏不是弗里德赖希共济失调的遗传缺陷。